Skip to main content

ADVERTISEMENT

Mitral regurgitation

Clinical Images
02/24/2018

Sivasankaran Sivasubramonian, DM;  Arun Gopalakrishnan, DM;  Bijulal Sasidharan, DM;  Ajitkumar Valaparambil, DM

Sivasankaran Sivasubramonian, DM;  Ar...
Transient elevation of LV diastolic pressure above LA pressure can occur in severe aortic regurgitation in the diastasis phase. Mitral E wave reversal in such a situation could serve as non-invasive evidence of elevated left ventricular...
Transient elevation of LV diastolic pressure above LA pressure can occur in severe aortic regurgitation in the diastasis phase. Mitral E wave reversal in such a situation could serve as non-invasive evidence of elevated left ventricular...
Transient elevation of LV...
02/24/2018
Journal of Invasive Cardiology
Clinical Images
01/29/2018

Farshad Forouzandeh, MD, PhD1 and John S. Douglas, Jr, MD2

Farshad Forouzandeh, MD, PhD1 and Joh...
A 79-year-old woman had an atretic LIMA to LAD but without significant LAD stenosis, patent SVG to OM1, patent SVG to RCA, and severe tandem lesions in a very tortuous LCX for which she underwent PCI. Placement of a BMW coronary guidewire...
A 79-year-old woman had an atretic LIMA to LAD but without significant LAD stenosis, patent SVG to OM1, patent SVG to RCA, and severe tandem lesions in a very tortuous LCX for which she underwent PCI. Placement of a BMW coronary guidewire...
A 79-year-old woman had an...
01/29/2018
Journal of Invasive Cardiology
12/27/2017

Claire E. Raphael, MBBS, PhD;  Elad Maor, MD, PhD;  Sidakpal S. Panaich, MD;  Guy Reeder, MD;  Charanjit S. Rihal, MD, MBA;  Mackram F. Eleid, MD

Claire E. Raphael, MBBS, PhD;  Elad M...
We assess the utility of intraprocedural reinfusion of blood aspirated during MitraClip implantation.
We assess the utility of intraprocedural reinfusion of blood aspirated during MitraClip implantation.
We assess the utility of...
12/27/2017
Journal of Invasive Cardiology
Clinical Images
07/01/2016

Vincenzo Pestrichella, MD1;  Antonio Pignatelli, MD1;  Rossella Alemanni, MD1;  Rosamaria Montesanti, MD1;  Maurizio Braccio, MD1;  Francesco Greco, MD1;  Pierpaolo D‚ÄôAmbruoso, MD1;  Cataldo Davide Memmola, MD1;  Mauro Cassese, MD1;  Gaetano Contegiacomo, MD1;  Rodrigo Bagur, MD, PhD2

 

Vincenzo Pestrichella, MD1;  Antonio ...
Two Occlutech paravalvular leak devices were successfully delivered in a 67-year-old patient with rheumatic heart valve disease using a simultaneous double-transapical access with double-wire technique.
Two Occlutech paravalvular leak devices were successfully delivered in a 67-year-old patient with rheumatic heart valve disease using a simultaneous double-transapical access with double-wire technique.
Two Occlutech paravalvular leak...
07/01/2016
Journal of Invasive Cardiology
Commentary
03/01/2016

Ted Feldman, MD and Mayra Guerrero, MD

 
Ted Feldman, MD and Mayra Guerrero, M...
While the role of mitral repair for degenerative mitral regurgitation is clear, we continue to struggle with whether treating FMR in the setting of LV dysfunction is ultimately beneficial.
While the role of mitral repair for degenerative mitral regurgitation is clear, we continue to struggle with whether treating FMR in the setting of LV dysfunction is ultimately beneficial.
While the role of mitral repair...
03/01/2016
Journal of Invasive Cardiology
Original Contribution
01/15/2016

Norbert Klein, MD1;  Dietrich Pfeiffer, MD, Prof1;  Steven Goldberg, MD2;  Maika Klein, MD1 

Norbert Klein, MD1;  Dietrich Pfeiffe...
This study evaluates the implantation success and hemodynamic results of the Carillon Mitral Contour System. 
This study evaluates the implantation success and hemodynamic results of the Carillon Mitral Contour System. 
This study evaluates the...
01/15/2016
Journal of Invasive Cardiology
04/29/2015

Christian Frerker, MD1;  Jury Schewel, MD1;  Dimitry Schewel, MD1;  Peter Wohlmuth2;  Tobias Schmidt, MD1; Felix Kreidel, MD1;  Ralf Bader, MD3;  Karl-Heinz Kuck, MD1;  Ulrich Sch√§fer, MD1

Christian Frerker, MD1;  Jury Schewel...
This study compares both the feasibility and outcomes of “off-label” transcatheter aortic valve replacement (TAVR) patients (n=156) with a standard “on-label” TAVR population (n=435) at a single institution. 
This study compares both the feasibility and outcomes of “off-label” transcatheter aortic valve replacement (TAVR) patients (n=156) with a standard “on-label” TAVR population (n=435) at a single institution. 
This study compares both the...
04/29/2015
Journal of Invasive Cardiology
01/09/2015

Paolo Scacciatella, MD1;  Sebastiano Marra, MD1;  Alberto Pullara, MD1,2;  Federico Conrotto, MD1;  
Matteo Marchetti, MD1,2;  Gaetana Ferraro, MD1;  Marco Pavani, MD1,2;  Luigi Biasco, MD1,2;  
Dario Bongiovanni, MD1;  Fiorenzo Gaita, Prof, MD1,2;  Fulvio Orzan, MD1,2

Paolo Scacciatella, MD1;  Sebastiano ...
An investigation of the very long-term clinical outcomes of atrial septal defect (ASD) percutaneous closure in adult patients and evaluation of the 12-month effects of the device on aortic and mitral valve function. Transcatheter ASD closure...
An investigation of the very long-term clinical outcomes of atrial septal defect (ASD) percutaneous closure in adult patients and evaluation of the 12-month effects of the device on aortic and mitral valve function. Transcatheter ASD closure...
An investigation of the very...
01/09/2015
Journal of Invasive Cardiology
Review
05/06/2010

Ted Feldman, MD, FESC, FACC, FSCAI

Ted Feldman, MD, FESC, FACC, FSCAI ...
Percutaneous therapy has emerged over the past few years as a rapidly progressing field of development for the treatment of mitral regurgitation. Most of the new percutaneous approaches are modifications of previously-described surgical...
Percutaneous therapy has emerged over the past few years as a rapidly progressing field of development for the treatment of mitral regurgitation. Most of the new percutaneous approaches are modifications of previously-described surgical...
Percutaneous therapy has emerged...
05/06/2010
Vascular Disease Management